Trial · NCT00829283
Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care
NCT00829283, Not applicable, Completed, Yale University; results first posted 2016-02-01
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care. Trials, record NCT00829283. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00829283
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care
- NCT number
- NCT00829283
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 191 participants, actual
- Lead sponsor
- Yale University
- Conditions
- Obesity, Binge Eating
- Interventions
- Behavioral Weight Loss, Behavioral Weight Loss + Guided self-help Cognitive-behavioral Therapy, Placebo, Sibutramine/Orlistat
- First posted
- 2009-01-27
- Last updated
- 2020-04-03
- Results first posted
- 2016-02-01
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Subjects Who Reached Binge Eating Remission | 12 months follow-up | Binge Remission (abstinence from binge eating) |
| Secondary | BMI | 12 months follow-up post-treatment | The body mass index is a value derived from the mass and height of an individual. The BMI is defined as the body mass divided by the square of the body height, and is universally expressed in units of kg/m\^2. |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Subjects Who Reached Binge Eating Remission | 12 months follow-up | participants | NUMBER | |
| SECONDARY | BMI | 12 months follow-up post-treatment | kg/m^2 | MEAN |
Source ClinicalTrials.gov
Results by group4
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Subjects Who Reached Binge Eating Remission | Standard Care | 16 | participants | ||
| Number of Subjects Who Reached Binge Eating Remission | Stepped-care | 65 | participants | ||
| BMI | Standard Care | 35.9 | Standard Deviation 6.6 | kg/m^2 | |
| BMI | Stepped-care | 37.1 | Standard Deviation 6.7 | kg/m^2 |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Standard Care | 39 | |
| Overall Study | STARTED | Stepped-care | 152 | |
| Overall Study | COMPLETED | Standard Care | 32 | |
| Overall Study | COMPLETED | Stepped-care | 127 | |
| Overall Study | NOT COMPLETED | Standard Care | 7 | |
| Overall Study | NOT COMPLETED | Stepped-care | 25 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Standard Care | ||
| Total, all-cause mortality | Stepped-care | ||
| Total, other adverse events | Standard Care | 0 | 39 |
| Total, other adverse events | Stepped-care | 0 | 152 |
| Total, serious adverse events | Standard Care | 0 | 39 |
| Total, serious adverse events | Stepped-care | 0 | 152 |
Source ClinicalTrials.gov
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| R01DK049587 | Behavioral and Pharmacologic Treatment of Binge Eating and Obesity | GRILO, CARLOS M | YALE UNIVERSITY | NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES | 2002 to 2020 |
Source NIH RePORTER
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Stepped-care vs Standard Care: Number of Subjects Who Reached Binge Eating Remission | Trial comparisons |
| Stepped-care vs Standard Care: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00829283
GET https://conductscience.org/api/trials/v1/NCT00829283/registered